Metastatic bone disease: Role of transcription factors and future targets
- 1 June 2010
- Vol. 48 (1), 30-36
- https://doi.org/10.1016/j.bone.2010.05.035
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial–stromal interactionsMolecular and Cellular Endocrinology, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- The cancer‐related Runx2 protein enhances cell growth and responses to androgen and TGFβ in prostate cancer cellsJournal of Cellular Biochemistry, 2010
- Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle GenesMolecular Therapy, 2010
- Runx2 regulates survivin expression in prostate cancer cellsLaboratory Investigation, 2009
- Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKLEuropean Journal of Pharmacology, 2009
- Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancerEuropean Journal Of Cancer, 2009
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer MetastasisCell, 2009
- Elevated expression of Runx2 as a key parameter in the etiology of osteosarcomaMolecular Biology Reports, 2008
- Histopathological Assessment of Prostate Cancer Bone Osteoblastic MetastasesJournal of Urology, 2008